PHARMACOLOGY FINAL EXAM
REVIEW!!!! GRADE A+ COMPLETE
EXAM QUESTIONS AND 100% VERIFIED
ANSWERS (2026/2027) PASS
GUARANTEE
AEpatientEaboutEtoEreceiveEhisEmorningEdoseEofEdigoxinEhasEanEapicalEpulseEofE70EbeatsEperEminute
.EWhatEwillEtheEnurseEdo?
A.EAdministerEtheEdose.
B.EAdministerEtheEdoseEandEnotifyEtheEphysician.
C.ECheckEtheEradialEpulseEforE1EfullEminute.
D.EWithholdEtheEdoseEandEnotifyEtheE-ECORRECTEANSWERA.EAdministerEtheEdose.
InEassessingEaEpatientEbeforeEadministrationEofEaEcardiacEglycoside,EtheEnurseEknowsEthatEwhatEco
nditionEcanEpredisposeEaEpatientEtoEdigitalisEtoxicity?
A.EHypokalemia
B.EHyperkalemia
C.EHypocalcemia
D.EHypernatremiaE-
ECORRECTEANSWERA.EHypokalemia;EcontrolEventricularEresponseEtoEatrialEfibrillationEandEaEderive
dEfromEfoxglove.EDigoxinEisEtheEonlyEavailableEcardiacEglycoside---positiveEinotropic---
inhibitsEsodiumEpotassiumEpumpE(adenosineEtripphophatase)ESodiumEandEcalciumErise.ECholinerg
icEstimulationEviaEtheEvagusEnerveEofEParasympatheticEnervousEsystem.E---NegativeEchronotropic--
-NegativeEDromotropicEeffect
WhileEassessingEaEpatientEwhoEisEreceivingEintravenousEdigitalis,EtheEnurseErecognizesEthatEtheEdru
gEhasEaEnegativeEchronotropicEeffect.EHowEwouldEthisEdrugEeffectEbeEevidentEinEtheEpatient?
A.EIncreasedEheartErate
B.EDecreasedEheartErate
,C.EDecreasedEconduction
D.EIncreasedEectopicEbeatsE-ECORRECTEANSWERB.EDecreasedEheartErate
AEpatientEhasEbeenEtakingEdigoxinEatEhomeEbutEhasEtakenEanEaccidentalEoverdoseEandEhasEdevelop
edEtoxicity.EHeEhasEbeenEadmittedEtoEtheEtelemetryEunitEwhereEtheEphysicianEhasEorderedEdigoxinEi
mmuneEFabE(Digibind).ETheEpatientEasksEtheEnurseEwhyEtheEmedicationEisEordered.EWhatEisEtheEnu
rse'sEbestEresponse?
A.E"ItEworksEfasterEthanEdigoxin."
B.E"ItEisEsaferEthanEdigoxinEandEcanEbeEtakenEorally."
C.E"ItEhelpsEtoEconvertEtheEirregularEheartErhythmEtoEaEmoreEnormalErhythm."
D.E"ThisEdrugEisEanEantidoteEtoEdigoxinEandEwillEhelpEtoElowerEtheEbloodElevels."E-
ECORRECTEANSWERD.E"ThisEdrugEisEanEantidoteEtoEdigoxinEandEwillEhelpEtoElowerEtheEbloodElevels.
"E(severeEbradycardia,EadvancedEheartEblock,EventricularrEtachycardia,Efibrillation,EandEhyperkale
mia);EavailableEinEparentalEform.EClinicalEsignsEandEsymptomsEareEmonitoredENOTEserumElevels----
usedEforEsystolicEheartEfailureEandEatrialEfibrillation.
5.EAEpatientEhasEbeenEplacedEonEaEmilrinoneEinfusionEasEpartEofEtheEtherapyEforEend-
stageEheartEfailure.EWhatErisksEinvolvedEwithEthisEdrugEwillEtheEnurseEkeepEinEmindEwhileEassessingE
thisEpatientEduringEtheEinfusion?
A.EHypertension
B.EHyperkalemia
C.ENauseaEandEvomiting
D.ECardiacEdysrhythmiasE-
ECORRECTEANSWERD.ECardiacEdysrhythmiasE(contraindictatedEwithEventricularEtachycardia,EandEfi
brillation)EusedEforEtreatmentEofEatrialEfibrillation.EAvailableEinEOralEandEinjectionEform.
6.EAEpatientEwithEatrialEfibrillationEwasEstartedEonEdigoxin,EandE1EweekElaterEaEdigoxinElevelEwasEdra
wn.EWhichEresultEisEwithinEnormalEtherapeuticElevelsEforEdigoxin?
A.E0.4Eng/mL
B.E0.7Eng/mL
,C.E2.1Eng/mL
D.E2.6Eng/mLEorEhigherE-ECORRECTEANSWERB.E0.7Eng/mLE(normalE0.5EtoE2.0Eng/mL
7.EWhenEreviewingEtheElistEofEmedicationsEtakenEbyEaEpatientEwhoEwillEbeEreceivingEaEnewEprescrip
tionEforEdigoxin,EtheEnurseEwouldEbeEconcernedEaboutEwhichEmedicationEthatEmayEinteractEwithEth
eEdigoxin?
A.Easpirin
B.EacetaminophenE(Tylenol)
C.EfurosemideE(Lasix)
D.EvitaminEKE-
ECORRECTEANSWERC.EfurosemideE(Lasix);E(loopEDiuretics);EnumerousEonesEonEpageE341
8.ETheEnurseEisEreviewingEdischargeEteachingEforEaEpatientEwhoEwillEbeEtakingEdigoxinE(Lanoxin)Ethe
rapy.ETheEpatientEshouldEbeEtaughtEtoEavoidEwhichEfoodsEwhenEtakingEtheEdigoxin?
A.ELeafyEgreenEvegetables
B.EDairyEproducts
C.EGrapefruitEjuice
D.EBranEmuffinsE-ECORRECTEANSWERD.EBranEmuffins
9.EInEassessingEaEpatientEbeforeEadministrationEofEaEcardiacEglycoside,EtheEnurseEknowsEthatEwhichE
labEresultEcanEincreaseEtheEtoxicityEofEtheEdrug?
A.EPotassiumElevelE2.8EmEq/L
B.EPotassiumElevelE4.9EmEq/L
C.ESodiumElevelE140EmEq/L
D.ECalciumElevelE10Emg/dLE-
ECORRECTEANSWERA.EPotassiumElevelE2.8EmEq/LE(lowEpotassiumEnormalEisE3.5EtoE5.0)
, 10.ETheEnurseEadministeringEtheEphosphodiesteraseEinhibitorEinamrinoneErecognizesEthatEthisEdru
gEshouldEhaveEaEpositiveEinotropicEeffect.EThisEeffectEwillEresultEinEincreased
A.EheartErate.
B.EbloodEvesselEdilation.
C.EforceEofEcardiacEcontraction.
D.EconductionEofEelectricalEimpulsesEacrossEtheEheart.E-
ECORRECTEANSWERC.EforceEofEcardiacEcontraction.E(increaseEcAMP)EpositiveEinotropicE(byEmoreEc
alciumEavailableEinESR)effectEandEvasodilation,E(inodilators)---
positiveEchornotropicEeffect);EUSEDEINEICU;EADVERSEEEFFECT...thrombocytopenia,Edysrhythmia,Ev
entricular,EhypotensionEandEangina,Ehypokalemia,Etremor.
11.ETheEnurseEnotesEinEaEpatient'sEmedicalErecordEthatEnesiritideEhasEbeenEordered.EBasedEonEthisE
order,EtheEnurseEinterpretsEthatEtheEpatientEhasEwhichEdisorder?
A.EAtrialEfibrillation
B.EAcutelyEdecompensatedEheartEfailureEwithEdyspneaEatErest
C.ESystolicEheartEfailure
D.ELong-termEtreatmentEofEheartEfailure.E-
ECORRECTEANSWERB.EAcutelyEdecompensatedEheartEfailureEwithEdyspneaEatErest
SELECTEALLETHATEAPPLY:
1.EWhenEaEpatientEisEexperiencingEdigoxinEtoxicity,EwhichEclinicalEsituationEwouldEnecessitateEtheE
E
useEofEdigoxinEimmuneEFabE(Digibind)?ESelectEallEthatEapply.
A.ETheEpatientEreportsEseeingEcolorfulEhalosEaroundElights.
B.ETheEpatient'sEserumEpotassiumElevelEisEaboveE5EmEq/L.
C.ETheEpatientEisEexperiencingEnauseaEandEanorexia.
D.ETheEpatientEisEexperiencingEsevereEsinusEbradycardiaEthatEdoesEnotErespondEtoEcardiacEpacing.
E.ETheEpatientEhasEtakenEanEoverdoseEofEgreaterEthanE10EmgEofEdigoxin.E-
ECORRECTEANSWERB.ETheEpatient'sEserumEpotassiumElevelEisEaboveE5EmEq/L.
REVIEW!!!! GRADE A+ COMPLETE
EXAM QUESTIONS AND 100% VERIFIED
ANSWERS (2026/2027) PASS
GUARANTEE
AEpatientEaboutEtoEreceiveEhisEmorningEdoseEofEdigoxinEhasEanEapicalEpulseEofE70EbeatsEperEminute
.EWhatEwillEtheEnurseEdo?
A.EAdministerEtheEdose.
B.EAdministerEtheEdoseEandEnotifyEtheEphysician.
C.ECheckEtheEradialEpulseEforE1EfullEminute.
D.EWithholdEtheEdoseEandEnotifyEtheE-ECORRECTEANSWERA.EAdministerEtheEdose.
InEassessingEaEpatientEbeforeEadministrationEofEaEcardiacEglycoside,EtheEnurseEknowsEthatEwhatEco
nditionEcanEpredisposeEaEpatientEtoEdigitalisEtoxicity?
A.EHypokalemia
B.EHyperkalemia
C.EHypocalcemia
D.EHypernatremiaE-
ECORRECTEANSWERA.EHypokalemia;EcontrolEventricularEresponseEtoEatrialEfibrillationEandEaEderive
dEfromEfoxglove.EDigoxinEisEtheEonlyEavailableEcardiacEglycoside---positiveEinotropic---
inhibitsEsodiumEpotassiumEpumpE(adenosineEtripphophatase)ESodiumEandEcalciumErise.ECholinerg
icEstimulationEviaEtheEvagusEnerveEofEParasympatheticEnervousEsystem.E---NegativeEchronotropic--
-NegativeEDromotropicEeffect
WhileEassessingEaEpatientEwhoEisEreceivingEintravenousEdigitalis,EtheEnurseErecognizesEthatEtheEdru
gEhasEaEnegativeEchronotropicEeffect.EHowEwouldEthisEdrugEeffectEbeEevidentEinEtheEpatient?
A.EIncreasedEheartErate
B.EDecreasedEheartErate
,C.EDecreasedEconduction
D.EIncreasedEectopicEbeatsE-ECORRECTEANSWERB.EDecreasedEheartErate
AEpatientEhasEbeenEtakingEdigoxinEatEhomeEbutEhasEtakenEanEaccidentalEoverdoseEandEhasEdevelop
edEtoxicity.EHeEhasEbeenEadmittedEtoEtheEtelemetryEunitEwhereEtheEphysicianEhasEorderedEdigoxinEi
mmuneEFabE(Digibind).ETheEpatientEasksEtheEnurseEwhyEtheEmedicationEisEordered.EWhatEisEtheEnu
rse'sEbestEresponse?
A.E"ItEworksEfasterEthanEdigoxin."
B.E"ItEisEsaferEthanEdigoxinEandEcanEbeEtakenEorally."
C.E"ItEhelpsEtoEconvertEtheEirregularEheartErhythmEtoEaEmoreEnormalErhythm."
D.E"ThisEdrugEisEanEantidoteEtoEdigoxinEandEwillEhelpEtoElowerEtheEbloodElevels."E-
ECORRECTEANSWERD.E"ThisEdrugEisEanEantidoteEtoEdigoxinEandEwillEhelpEtoElowerEtheEbloodElevels.
"E(severeEbradycardia,EadvancedEheartEblock,EventricularrEtachycardia,Efibrillation,EandEhyperkale
mia);EavailableEinEparentalEform.EClinicalEsignsEandEsymptomsEareEmonitoredENOTEserumElevels----
usedEforEsystolicEheartEfailureEandEatrialEfibrillation.
5.EAEpatientEhasEbeenEplacedEonEaEmilrinoneEinfusionEasEpartEofEtheEtherapyEforEend-
stageEheartEfailure.EWhatErisksEinvolvedEwithEthisEdrugEwillEtheEnurseEkeepEinEmindEwhileEassessingE
thisEpatientEduringEtheEinfusion?
A.EHypertension
B.EHyperkalemia
C.ENauseaEandEvomiting
D.ECardiacEdysrhythmiasE-
ECORRECTEANSWERD.ECardiacEdysrhythmiasE(contraindictatedEwithEventricularEtachycardia,EandEfi
brillation)EusedEforEtreatmentEofEatrialEfibrillation.EAvailableEinEOralEandEinjectionEform.
6.EAEpatientEwithEatrialEfibrillationEwasEstartedEonEdigoxin,EandE1EweekElaterEaEdigoxinElevelEwasEdra
wn.EWhichEresultEisEwithinEnormalEtherapeuticElevelsEforEdigoxin?
A.E0.4Eng/mL
B.E0.7Eng/mL
,C.E2.1Eng/mL
D.E2.6Eng/mLEorEhigherE-ECORRECTEANSWERB.E0.7Eng/mLE(normalE0.5EtoE2.0Eng/mL
7.EWhenEreviewingEtheElistEofEmedicationsEtakenEbyEaEpatientEwhoEwillEbeEreceivingEaEnewEprescrip
tionEforEdigoxin,EtheEnurseEwouldEbeEconcernedEaboutEwhichEmedicationEthatEmayEinteractEwithEth
eEdigoxin?
A.Easpirin
B.EacetaminophenE(Tylenol)
C.EfurosemideE(Lasix)
D.EvitaminEKE-
ECORRECTEANSWERC.EfurosemideE(Lasix);E(loopEDiuretics);EnumerousEonesEonEpageE341
8.ETheEnurseEisEreviewingEdischargeEteachingEforEaEpatientEwhoEwillEbeEtakingEdigoxinE(Lanoxin)Ethe
rapy.ETheEpatientEshouldEbeEtaughtEtoEavoidEwhichEfoodsEwhenEtakingEtheEdigoxin?
A.ELeafyEgreenEvegetables
B.EDairyEproducts
C.EGrapefruitEjuice
D.EBranEmuffinsE-ECORRECTEANSWERD.EBranEmuffins
9.EInEassessingEaEpatientEbeforeEadministrationEofEaEcardiacEglycoside,EtheEnurseEknowsEthatEwhichE
labEresultEcanEincreaseEtheEtoxicityEofEtheEdrug?
A.EPotassiumElevelE2.8EmEq/L
B.EPotassiumElevelE4.9EmEq/L
C.ESodiumElevelE140EmEq/L
D.ECalciumElevelE10Emg/dLE-
ECORRECTEANSWERA.EPotassiumElevelE2.8EmEq/LE(lowEpotassiumEnormalEisE3.5EtoE5.0)
, 10.ETheEnurseEadministeringEtheEphosphodiesteraseEinhibitorEinamrinoneErecognizesEthatEthisEdru
gEshouldEhaveEaEpositiveEinotropicEeffect.EThisEeffectEwillEresultEinEincreased
A.EheartErate.
B.EbloodEvesselEdilation.
C.EforceEofEcardiacEcontraction.
D.EconductionEofEelectricalEimpulsesEacrossEtheEheart.E-
ECORRECTEANSWERC.EforceEofEcardiacEcontraction.E(increaseEcAMP)EpositiveEinotropicE(byEmoreEc
alciumEavailableEinESR)effectEandEvasodilation,E(inodilators)---
positiveEchornotropicEeffect);EUSEDEINEICU;EADVERSEEEFFECT...thrombocytopenia,Edysrhythmia,Ev
entricular,EhypotensionEandEangina,Ehypokalemia,Etremor.
11.ETheEnurseEnotesEinEaEpatient'sEmedicalErecordEthatEnesiritideEhasEbeenEordered.EBasedEonEthisE
order,EtheEnurseEinterpretsEthatEtheEpatientEhasEwhichEdisorder?
A.EAtrialEfibrillation
B.EAcutelyEdecompensatedEheartEfailureEwithEdyspneaEatErest
C.ESystolicEheartEfailure
D.ELong-termEtreatmentEofEheartEfailure.E-
ECORRECTEANSWERB.EAcutelyEdecompensatedEheartEfailureEwithEdyspneaEatErest
SELECTEALLETHATEAPPLY:
1.EWhenEaEpatientEisEexperiencingEdigoxinEtoxicity,EwhichEclinicalEsituationEwouldEnecessitateEtheE
E
useEofEdigoxinEimmuneEFabE(Digibind)?ESelectEallEthatEapply.
A.ETheEpatientEreportsEseeingEcolorfulEhalosEaroundElights.
B.ETheEpatient'sEserumEpotassiumElevelEisEaboveE5EmEq/L.
C.ETheEpatientEisEexperiencingEnauseaEandEanorexia.
D.ETheEpatientEisEexperiencingEsevereEsinusEbradycardiaEthatEdoesEnotErespondEtoEcardiacEpacing.
E.ETheEpatientEhasEtakenEanEoverdoseEofEgreaterEthanE10EmgEofEdigoxin.E-
ECORRECTEANSWERB.ETheEpatient'sEserumEpotassiumElevelEisEaboveE5EmEq/L.